Pharmacological treatment for psychotic depression
- 19 October 2005
- reference entry
- Published by Wiley
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Effect of Antidepressant Medication Resistance on Short-term Response to Electroconvulsive TherapyJournal of Clinical Psychopharmacology, 2004
- Prevalence of Depressive Episodes With Psychotic Features in the General PopulationAmerican Journal of Psychiatry, 2002
- Faster Onset of Action of Fluvoxamine in Combination With Pindolol in the Treatment of Delusional DepressionJournal of Clinical Psychopharmacology, 1998
- Psychotic DepressionCNS Drugs, 1997
- Lithium-TCA Combination Treatment of Psychotic DepressionJournal of Clinical Psychopharmacology, 1997
- Moclobemide: a reversible MAO-A-inhibitor showing weaker antidepressant effect than clomipramine in a controlled multicenter studyJournal of Affective Disorders, 1993
- Who Benefits from Electroconvulsive Therapy?The British Journal of Psychiatry, 1992
- A Placebo-controlled Study of the Antidepressant Activity of Moclobemide,A New MAO-A InhibitorPharmacopsychiatry, 1984
- Delusional depression*Phenomenology, neuroendocrine function, and tricyclic antidepressant responseJournal of Affective Disorders, 1984
- Imipramine (Tofranil) vs. placebo in hospitalized psychotic depressives (A comparison of patients' self-ratings, psychiatrists' ratings and psychological test scores)Journal of Psychiatric Research, 1966